Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louis, E. D.
Right arrow Articles by Mayeux, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, E. D.
Right arrow Articles by Mayeux, R.
Related Collections
Right arrow All Movement Disorders
Right arrow Parkinson's disease/Parkinsonism
Right arrow All epidemiology
Right arrow Prevalence studies
Right arrow Risk factors in epidemiology

Neurology 2003;61:24-28
© 2003 American Academy of Neurology

Parkinsonian signs in older people

Prevalence and associations with smoking and coffee

Elan D. Louis, MD MS, Jose A. Luchsinger, MD MPH, Ming X. Tang, PhD and Richard Mayeux, MD MSc

From the Gertrude H. Sergievsky Center (Drs. Louis, Tang, and Mayeux), Departments of Neurology (Drs. Louis and Mayeux), Medicine (Dr. Luchsinger), Biostatistics (Drs. Tang and Mayeux), and Psychiatry (Dr. Mayeux), and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain (Drs. Louis and Mayeux), Columbia University, New York, NY.

Address correspondence and reprint requests to Dr. E.D. Louis, Unit 198, Neurological Institute, 710 W. 168 St., New York, NY 10032; e-mail: EDL2{at}columbia.edu

Background: Cigarette smoking and coffee consumption may reduce the risk of PD. Parkinsonian signs (tremor, rigidity, bradykinesia) occur in 30 to 40% of the elderly.

Objective: To determine whether there was an association between cigarette smoking, coffee consumption, and parkinsonian signs in a community population of older people.

Methods: Data on smoking were collected and a neurologic examination performed on 1,339 residents >=65 years of age in the Washington Heights–Inwood community in northern Manhattan, NY. Parkinsonian signs were rated with an abbreviated Unified Parkinson’s Disease Rating Scale, resulting in a parkinsonian sign score. Coffee consumption was assessed with a semiquantitative food-frequency questionnaire, and caffeine consumption was determined. Analyses were cross-sectional.

Results: Mean age was 76.6 years. Parkinsonian signs were present in 537 (40.1%). The odds for presence of parkinsonian signs was lower in smokers than nonsmokers (odds ratio [OR] = 0.58, 95% CI = 0.47 to 0.73). Smokers had a lower mean parkinsonian sign score than nonsmokers (p < 0.001). Coffee drinking and caffeine consumption were not associated with the presence of parkinsonian signs. The odds for presence of parkinsonian signs remained lower in smokers (OR = 0.75, 95% CI = 0.57 to 0.99) after adjusting for age, gender, ethnicity, years of education, adjusted daily caffeine consumption, and dementia.

Conclusion: The reduced risk of parkinsonian signs in cigarette smokers could reflect a protective effect of smoking on age-related parkinsonian signs in the elderly or an aversion to smoking in elderly persons with mild parkinsonism.




This article has been cited by other articles:


Home page
Arch NeurolHome page
E. D. Louis, A. M. Brickman, C. DeCarli, S. A. Small, K. Marder, N. Schupf, and T. R. Brown
Quantitative Brain Measurements in Community-Dwelling Elderly Persons With Mild Parkinsonian Signs
Arch Neurol, December 1, 2008; 65(12): 1649 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Guerreiro, D. Toulorge, E. Hirsch, M. Marien, P. Sokoloff, and P. P. Michel
Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
Mol. Pharmacol., October 1, 2008; 74(4): 980 - 989.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. D. Louis, N. Schupf, M. X. Tang, K. Marder, and J. A. Luchsinger
Mild Parkinsonian Signs and Plasma Homocysteine Concentration in Community-Dwelling Elderly Individuals
Arch Neurol, November 1, 2007; 64(11): 1646 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
D. B. Hancock, E. R. Martin, J. M. Stajich, R. Jewett, M. A. Stacy, B. L. Scott, J. M. Vance, and W. K. Scott
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease
Arch Neurol, April 1, 2007; 64(4): 576 - 580.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. D. Louis and J. A. Luchsinger
History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals.
Arch Neurol, May 1, 2006; 63(5): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. D. Louis, N. Schupf, J. Manly, K. Marder, M. X. Tang, and R. Mayeux
Association between mild parkinsonian signs and mild cognitive impairment in a community
Neurology, April 12, 2005; 64(7): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. D. Louis, M. X. Tang, N. Schupf, and R. Mayeux
Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People
Arch Neurol, February 1, 2005; 62(2): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Z. Arvanitakis, R. S. Wilson, J. A. Schneider, J. L. Bienias, D. A. Evans, and D. A. Bennett
Diabetes mellitus and progression of rigidity and gait disturbance in older persons
Neurology, September 28, 2004; 63(6): 996 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. D. Louis, M. X. Tang, and R. Mayeux
Parkinsonian Signs in Older People in a Community-Based Study: Risk of Incident Dementia
Arch Neurol, August 1, 2004; 61(8): 1273 - 1276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.